Natural killer cells, ageing and cancer Elissaveta NaumovaGraham PawelecAnastasiya Mihaylova Editorial 11 March 2016 Pages: 367 - 370
Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy Ruan Felipe Vieira MedranoJoão Paulo Portela CataniBryan E. Strauss Original Article 18 February 2016 Pages: 371 - 382
A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2 Julia M. GreeneErika J. SchnebleGeorge E. Peoples Original Article 19 February 2016 Pages: 383 - 392
A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency Simone PuntEmilie A. C. DronkersEkaterina S. Jordanova Original Article Open access 22 February 2016 Pages: 393 - 403
Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node Mari F. C. M. van den HoutBerbel J. R. SluijterTanja D. de Gruijl Original Article Open access 02 March 2016 Pages: 405 - 415
Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance Angela R. ManserMarkus Uhrberg Symposium-in-writing paper 19 August 2015 Pages: 417 - 426
Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies Viktoria VarbanovaElissaveta NaumovaAnastasiya Mihaylova Symposium-in-Writing Paper 13 February 2016 Pages: 427 - 440
CD57 in human natural killer cells and T-lymphocytes Hassen KaredSerena MartelliAnis Larbi Symposium-in-Writing Paper 05 February 2016 Pages: 441 - 452
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies? Beatriz Sanchez-CorreaCarmen CamposRaquel Tarazona Symposium-in-writing paper 10 June 2015 Pages: 453 - 463
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias Gabriella PietraChiara VitaleLorenzo Moretta Symposium-in-writing paper 20 August 2015 Pages: 465 - 476
Selection and expansion of natural killer cells for NK cell-based immunotherapy Petra S. A. BeckerGarnet SuckChristian Seidl Symposium-in-writing paper Open access 25 January 2016 Pages: 477 - 484
NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy Garnet SuckMarcus OdendahlTorsten Tonn Symposium-in-writing paper 11 November 2015 Pages: 485 - 492